Daniel Anderson receives 2023 Wilhelm Exner Medal
Award honors researchers who “have had a direct impact on business and industry through their scientific achievements and contributions.”
Award honors researchers who “have had a direct impact on business and industry through their scientific achievements and contributions.”
The printer generates vaccine-filled microneedle patches that can be stored long-term at room temperature and applied to the skin.
In a new study, immunostimulatory drugs slowed tumor growth without producing systemic inflammation.
Using ultrasonic waves that propel drug molecules into the skin, the patch could be used to treat a variety of skin conditions.
The global health care company Sanofi is providing $25 million to advance RNA research.
Researchers develop new, patient-friendly hydrogel platform for administering lifesaving biologics.
With further development, the programmable system could be used in a range of applications including gene and cancer therapies.
MIT Open Learning team awarded NIH grant to provide training in biomedical product development, entrepreneurship, and innovation.
A new computational framework could help researchers design granular hydrogels to repair or replace diseased tissues.
Companies founded by MechE faculty and alumni solve a variety of health care challenges, from better drug delivery to robotic surgery.
Using bottlebrush-shaped particles, researchers can identify and deliver synergistic combinations of cancer drugs.
Metal stents or staples that disintegrate on demand inside the body could eliminate some surgical and endoscopic procedures.
A capsule that tunnels through mucus in the GI tract could be used to orally administer large protein drugs such as insulin.
A new device, which doesn’t rely on immunosuppressing drugs, may assist efforts to develop an artificial pancreas to treat diabetes.
The findings of a large-scale screen could help researchers design nanoparticles that target specific types of cancer.